Insulin therapy in type II diabetes.
When diet therapy is no longer effective in keeping the fasting plasma glucose level < 6 mmol l-1, a basal insulin supplement from a long-acting insulin such as ultralente can be added instead of using a sulphonylurea or metformin. The dose of insulin required can be predicted from the level...
Main Authors: | Holman, R, Turner, R |
---|---|
Format: | Conference item |
Published: |
1995
|
Similar Items
-
Intermediate acting insulin for type 2 diabetes.
by: Turner, R, et al.
Published: (1985) -
DIETARY EVALUATION IN TYPE-II DIABETIC SUBJECTS RANDOMLY ALLOCATED TO INSULIN, SULFONYLUREA OR DIET THERAPY
by: Eeley, E, et al.
Published: (1992) -
UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995) -
Addition of insulin to oral therapy in type 2 diabetes - Reply
by: Holman, R, et al.
Published: (2008) -
Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.
by: Holman, R, et al.
Published: (1987)